Current Opinion in Lipidology volume 30, issue 6, P438-445 2019 DOI: 10.1097/mol.0000000000000643 View full text
Chris J. Packard

Abstract: Purpose of the review: Cardiovascular disease prevention trials of lipid lowering with statins have shown unexpected long-term benefits after the formal randomized treatment stopped. This finding needs further exploration since it raises the possibility that the trajectory of the disease can be modified. Recent findings: Extended follow up data are now available from further major primary prevention studies and from meta-analyses of the legacy effect of statin trials. New outcome studies have been proposed and…

expand abstract